ReviewFrontiers in cardiovascular medicine2026
Expanding the scope of SGLT inhibitors in underrepresented cardiac populations: from pathophysiology to clinical evidence.
Banmeet Padda et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.